🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Check out our poster (board #147) looking at the predictive value of TILs in pts with TNBC treated with neoadjuvant chemotherapy in TBCRC 030 TILs assessed by pathologists and #AI algorithms were predictive of pathologic response Erica Mayer Dana-Farber’s Breast Oncology Center OncoAlert

We mourn the loss of pharmacologist Dr. V. Craig Jordan, who discovered Selective Estrogen Receptor Modulators (SERMs) and developed breakthrough breast cancer treatments. Read more about his legacy: bit.ly/3XlxJIx #EndCancer

Excited to represent Ajay Sheshadri at the MD Anderson Cancer Center #DoIM #CyrusAwardFinalist on our trastuzumab associated pneumonitis in #BreastCa project Lara Bashoura Jason A. Mouabbi MD Felipe Soto Maria Azhar UT Pulmonary Critical Care Sleep w/stellar panel Anita Deswal Seyed Moghaddam #MDAPulmonary

Tumor size & nodal involvement are the most validated prognostic indicators & are probably surrogates for biology. This study adds to mounting evidence that pCR in higher stage TNBC (& HER2+) has worse prognosis than lower stages and should be studied & treated differently.

Today we along with The Texas Heart Institute, @BiVACOR and St. Luke's Health hosted a press conference to announce the successful completion of the first-in-human implantation of the BiVACOR Total Artificial Heart as part of the U.S. FDA Early Feasibility Study. #HeartFailure #MedTech

Leadership isn’t just about making decisions; it’s about knowing when to act and when to hold back. The real cost of leadership is often paid in the currency of courage, accountability, and sometimes criticism. Are you ready to pay the price? #Leadership #Accountability #Courage

Everyone talks about change, but how often do we start with ourselves? True transformation begins when leaders model the self-awareness they hope to inspire in others. Let’s focus on what we can change within before pointing fingers. #SelfAwareness #PersonalGrowth #Leadership

Chaos can be a sign of either renewal or decline, depending on how it’s managed. Short-term disruption can spark innovation, but prolonged disorder without purpose may be a sign of deeper issues. Context matters!  #ChangeManagement #OrganizationalHealth #Leadership

Change can shake trust. For leaders, it’s a delicate balance—driving progress without losing followership. Communicate the ‘why’ behind changes, and people are more likely to stay engaged and committed #Trust #Leadership #OrganizationalChange

Blaming others may win short-term popularity, but accountability builds long-term respect. Ethical leaders inspire loyalty by owning both successes and setbacks. #EthicalLeadership #Integrity #Respect

As we gather and reflect on our blessings, let us not forget those for whom safety, peace, and abundance are out of reach. May we commit to act to end the suffering in Gaza and other war zones and build a world where everyone is free and has a chance to thrive. Happy Thanksgiving

Innovative session design and organization. Interactive and informative. Great job by the speakers and moderator. Ben Ho Park Heather Parsons Adrian Lee #SABCS2024

Now on #SABCSSnippets: Andrew Tutt, MB, ChB, PhD, talks with Julie Nangia, MD, about the results of the phase 3 OlympiA trial of adjuvant olaparib after (neo)adjuvant chemotherapy in patients with high-risk HER2- primary breast cancer. bit.ly/41xDWU2 #SABCS24

Nominations are still open for U.S. News & World Report's #Cancer hospital rankings! Show your support for Dan L Duncan Comprehensive Cancer Center innovative discoveries by nominating Dan L Duncan Comprehensive Cancer Center on Doximity today: Doximity.com BCMHouston. #CancerTwitter

Excellent overview of treatment for early stage HER2 positive disease by Mothaffar Rimawi - we need biomarkers to tailor therapy for this population MD Education VIRGINIA KAKLAMANI

Day 1 of the inaugural MD Education’s #BreastCancer US Focus Meeting, chaired by Dr. Sara Tolaney (Sara Tolaney) and Dr. Virginia Kaklamani (VIRGINIA KAKLAMANI), was a success! The day was filled with outstanding presentations and dynamic panel discussions, with more to come tomorrow.

Excellent #ASCO25 infographic highlighting the results of the DESTINY-Breast09 study: 👉Participants in the #TDXd + #Pertuzumab arm lived longer without their disease growing, spreading, or getting worse compared with participants in the THP (taxane + trastuzumab + pertuzumab)

Think you know how to use ET therapy for breast cancer? Think again! Masterclass talk on pitfalls and complexities of navigating best ET approach for ER+ early/late pre/post meno. #bcsm BCMHouston Dan L Duncan Comprehensive Cancer Center BCMCancerEd